Akebia Therapeutics (AKBA) Inventory: 2018-2025
Historic Inventory for Akebia Therapeutics (AKBA) over the last 7 years, with Sep 2025 value amounting to $18.6 million.
- Akebia Therapeutics' Inventory fell 9.03% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year decrease of 9.03%. This contributed to the annual value of $16.2 million for FY2024, which is 3.52% up from last year.
- According to the latest figures from Q3 2025, Akebia Therapeutics' Inventory is $18.6 million, which was up 11.58% from $16.7 million recorded in Q2 2025.
- In the past 5 years, Akebia Therapeutics' Inventory registered a high of $45.2 million during Q3 2022, and its lowest value of $15.7 million during Q4 2023.
- In the last 3 years, Akebia Therapeutics' Inventory had a median value of $19.7 million in 2025 and averaged $19.7 million.
- Its Inventory has fluctuated over the past 5 years, first slumped by 63.77% in 2021, then skyrocketed by 34.30% in 2022.
- Akebia Therapeutics' Inventory (Quarterly) stood at $36.6 million in 2021, then tumbled by 41.12% to $21.6 million in 2022, then decreased by 27.25% to $15.7 million in 2023, then rose by 3.52% to $16.2 million in 2024, then declined by 9.03% to $18.6 million in 2025.
- Its Inventory was $18.6 million in Q3 2025, compared to $16.7 million in Q2 2025 and $19.7 million in Q1 2025.